Michael David Weiss MD

Neurology•Seattle, WA

Neuroimmunology/Multiple Sclerosis, Neuromuscular Medicine

Professor, Neurology, University of Washington School of Medicine

Join to View Full Profile

1959 Ne Pacific StBox 356115Seattle, WA 98195
Phone+1 206-598-7688
Fax+1 206-568-7698

Summary

Dr. Michael Weiss is a neurologist in Seattle, WA and is affiliated with University of Washington Medical Center. He received his medical degree from Albert Einstein College of Medicine and has been in practice 26 years. He specializes in neuromuscular medicine and is experienced in general neurology, swallowing disorders, neuromuscular medicine, and clinical neurophysiology.

Education & Training

National Institutes of Health Clinical CenterFellowship, Neuroimmunology & Multiple Sclerosis, 1996 - 2000
University of Maryland Medical Center Midtown CampusNeuromuscular Disease, 1995 - 1996
MedStar Health Georgetown UniversityResidency, Neurology, 1992 - 1995
MedStar Health/Georgetown-Washington Hospital CenterInternship, Internal Medicine, 1991 - 1992
Albert Einstein College of MedicineClass of 1991

Certifications & Licensure

WA State Medical License 2001 - 2025
MD State Medical License 1995 - 2001
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

Top Doctor Seattle Magazine, 2017-2023
Top Doctors Castle Connolly, 2013-2023
Top Doctor Seattle Metropolitan Magazine, 2012-2014, 2017

Clinical Trials

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS) Start of enrollment: 2013 Jul 01
Completed
Phase 2
Therapy in Amyotrophic Lateral Sclerosis (TAME) Start of enrollment: 2018 Nov 07
Completed
Phase 2
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis Start of enrollment: 2016 Oct 01
Completed
Phase 2
Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis Start of enrollment: 2017 Oct 11
Completed
Phase 2
Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis Start of enrollment: 2019 Sep 17
COMPLETED
PHASE3
Safety Study of Oral Edaravone Administered in Subjects With ALS Start of enrollment: 2019 Nov 18
Completed
Phase 3
Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis Start of enrollment: 2019 Apr 17
Completed
Phase 1
Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) Start of enrollment: 2019 Oct 21
Active, not recruiting
HEALEY ALS Platform Trial - Master Protocol Start of enrollment: 2020 Jul 14
Active, not recruiting
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen C CNM-Au8 Start of enrollment: 2020 Jul 30
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen A Zilucoplan Start of enrollment: 2020 Jul 29
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen B Verdiperstat Start of enrollment: 2020 Jul 28
Completed
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
, Jinsy Andrews, Sabrina Paganoni, Eric A Macklin, Lori B Chibnik
JAMA Neurology. 2025-02-17
Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications.
Travis T Denton, Gregory T Carter, Megan Goddard, Jeremy Weiss, Douglas L Weeks
Muscle & Nerve. 2025-02-12
1 citations
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Sabrina Paganoni, Christina N Fournier, Eric A Macklin, Lori B Chibnik, Melanie Quintana
JAMA Network Open. 2025-02-03

Press Mentions

ALS Update: Drug Therapy Continues to Offer Little BenefitOctober 21st, 2024
Everything You Know About Muscle Cramps Is WrongDecember 29th, 2018
New Clinical Pilot Studies Will Use Biomarkers to Speed Therapy DevelopmentFebruary 10th, 2016

Committees

Member, NEALS Executive Committee 2017 - Present
Chair, Exam Committee, ABEM 2014 - 2017
Member, Exam Committee, ABEM 2014 - 2017
Member, Limb Girdle Muscular Dystrophy Guidelines Committee, AAN 2013 - 2014
Member, Marketing Committee, AANEM 2010 - 2012

Professional Memberships

American Academy of Neurology - AAN
Member
American Association of Neuromuscular Diseases and Electrodiagnostic Medicine
Member